V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310003272 | 310006572 | 1.66 | 77.1 | Palliative (P) | 2017-03-09 | 2017-03-10 | Ipilimumab | null | N | 310017595 | IPILIMUMAB |
| 310003273 | 310006572 | 1.77 | 96.85 | Palliative (P) | 2013-07-02 | 2013-07-08 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017595 | CISPLATIN + GEMCITABINE |
| 310003274 | 310006572 | null | null | Curative (C) | 2016-06-25 | 2016-07-06 | Retinoblastoma JOE | N | N | 310017595 | CEV |
| 310003275 | 310001387 | 1.61 | 81 | Palliative (P) | 2014-09-02 | 2014-09-04 | CHEMO-T TRIAL | Y | N | 310017601 | TRIAL |
| 310003276 | 310001388 | 1.53 | 49.25 | null | 2016-07-15 | 2016-07-15 | CHOP R - 21 days | 02 | N | 310017602 | CHOP R |
| 310003278 | 310006573 | 1.73 | 73.9 | Palliative (P) | 2015-03-02 | 2015-04-08 | Carboplatin + Etoposide iv&po | N | N | 310017611 | CARBOPLATIN + ETOPOSIDE |
| 310003279 | 310006573 | 0 | 75 | Curative (C) | 2017-07-03 | 2017-07-04 | Retinoblastoma JOE | N | N | 310017611 | CEV |
| 310003280 | 310010317 | 1.66 | null | Palliative (P) | 2014-06-26 | 2014-06-26 | Doxorubicin 75mg/m2 | N | null | 310017613 | DOXORUBICIN |
| 310003281 | 310010317 | 1.51 | null | Not known (9) | 2017-08-09 | 2017-08-09 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 310017613 | CISPLATIN + GEMCITABINE |
| 310003282 | 310010317 | 0 | 70.9 | Palliative (P) | 2018-04-10 | 2018-04-14 | Ipilimumab | 2 | N | 310017613 | IPILIMUMAB |
| 310003283 | 310010317 | 1.6 | 49.9 | Palliative (P) | null | 2014-03-24 | Cisplatin + Gemcitabine (D 1 & 8) | N | null | 310017613 | CISPLATIN + GEMCITABINE |
| 310003284 | 310001390 | 1.61 | 66 | Curative (C) | 2015-06-23 | 2015-08-27 | Cisplatin 7 day | N | Y | 310017620 | CISPLATIN |
| 310003285 | 310006574 | 1.28 | 72 | Palliative (P) | 2016-06-09 | 2016-06-09 | Trial Unspecified | 01 | null | 310017622 | TRIAL |
| 310003286 | 310006574 | 1.57 | 10.3 | Palliative (P) | null | 2014-03-23 | Doxorubicin 75mg/m2 | null | null | 310017622 | DOXORUBICIN |
| 310003287 | 310001391 | 1.7 | 96 | Curative (C) | 2013-11-05 | 2013-11-23 | Cisplatin | N | Y | 310017628 | CISPLATIN |
| 310003288 | 310001391 | 1.63 | 66.5 | Palliative (P) | 2018-03-03 | 2018-03-04 | Cisplatin + Gemcitabine (D 1 & 8) | null | N | 310017628 | CISPLATIN + GEMCITABINE |
| 310003289 | 310001391 | 1.86 | 113 | Disease modification (D) | null | 2014-05-09 | SMILE | 1 | null | 310017628 | TRIAL |
| 310003290 | 310001392 | null | 79.5 | Curative (C) | null | 2017-09-02 | Trial Unspecified | Y | N | 310017634 | TRIAL |
| 310003291 | 310001393 | 1.78 | 72.1 | null | 2013-06-14 | 2013-06-29 | PEMBROLIZUMAB | 99 | N | 310017636 | PEMBROLIZUMAB |
| 310003292 | 310001393 | 1.65 | 70.1 | Adjuvant (A) | 2014-12-18 | 2015-03-09 | Cisplatin + Gemcitabine (D 1 & 8) | Y | N | 310017636 | CISPLATIN + GEMCITABINE |
| 310003293 | 310001393 | 1.68 | 67.2 | Palliative (P) | 2017-06-03 | 2017-06-09 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | 310017636 | CISPLATIN + GEMCITABINE |
| 310003294 | 310001394 | 1.4 | 64.4 | Palliative (P) | 2015-09-11 | 2015-09-23 | Doxorubicin 75mg/m2 | N | N | 310017640 | DOXORUBICIN |
| 310003295 | 310006577 | null | 79.6 | Palliative (P) | 2014-08-12 | 2014-08-12 | Doxorubicin 75mg/m2 | N | N | 310017642 | DOXORUBICIN |
| 310003296 | 310006577 | null | 93.8 | Palliative (P) | 2018-12-03 | 2018-12-05 | CHEMO-T TRIAL | Y | N | 310017642 | TRIAL |
| 310003297 | 310006577 | 1.8 | null | Adjuvant (A) | 2015-08-30 | 2015-09-17 | Cisplatin 7 day | N | Y | 310017642 | CISPLATIN |
| 310003298 | 310006577 | 1.81 | 70 | Adjuvant (A) | 2015-11-25 | 2015-11-27 | Cisplatin 7 day | 02 | Y | 310017642 | CISPLATIN |
| 310003299 | 310011431 | 1.59 | null | null | 2015-11-22 | 2015-11-24 | Trial Unspecified | Y | N | 310017648 | TRIAL |
| 310003300 | 310011431 | null | 83 | Not known (9) | 2016-06-08 | 2016-06-19 | Ipilimumab | 02 | N | 310017648 | IPILIMUMAB |
| 310003301 | 310001395 | 1.52 | 52.1 | null | 2014-07-13 | 2014-07-13 | CHOP R | null | N | 310017651 | CHOP R |
| 310003302 | 310001395 | 1.57 | 7 | Curative (C) | 2018-01-03 | 2018-01-06 | Trial Unspecified | 01 | N | 310017651 | TRIAL |
| 310003303 | 310001395 | null | 83.2 | Palliative (P) | 2013-09-24 | 2013-09-26 | CHEMO-T TRIAL | Y | N | 310017651 | TRIAL |
| 310003304 | 310010319 | 0 | 72 | Curative (C) | 2013-09-01 | 2013-10-10 | Retinoblastoma JOE | N | Y | 310017655 | CEV |
| 310003305 | 310001396 | 1.66 | null | Palliative (P) | null | 2018-11-20 | PEMBROLIZUMAB | N | N | 310017658 | PEMBROLIZUMAB |
| 310003306 | 310001396 | 1.62 | 65.5 | Adjuvant (A) | 2018-06-24 | 2018-06-26 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | null | 310017658 | CISPLATIN + GEMCITABINE |
| 310003307 | 310001396 | null | 70.8 | Curative (C) | 2016-02-26 | 2016-03-21 | CHOP R - 21 days | null | N | 310017658 | CHOP R |
| 310003315 | 310001398 | 1.69 | null | null | 2015-01-09 | 2015-01-13 | Carboplatin + Etoposide IV 3 day | N | N | 310017687 | CARBOPLATIN + ETOPOSIDE |
| 310003316 | 310001399 | 1.75 | 95.8 | Palliative (P) | 2015-05-22 | 2015-06-03 | PEMBROLIZUMAB | 02 | N | 310017688 | PEMBROLIZUMAB |
| 310003317 | 310001399 | 1.06 | 86 | Curative (C) | 2014-01-19 | 2014-01-30 | Retinoblastoma JOE | N | N | 310017688 | CEV |
| 310003318 | 310001400 | 1.77 | -1 | Palliative (P) | 2016-06-01 | 2016-06-14 | CARBOPLATIN + ETOPOSIDE | N | N | 310017691 | CARBOPLATIN + ETOPOSIDE |
| 310003319 | 310001400 | null | null | Palliative (P) | 2014-08-25 | 2014-09-01 | Ipilimumab | 2 | N | 310017691 | IPILIMUMAB |
| 310003320 | 310001401 | null | 78 | Palliative (P) | 2017-10-08 | 2017-10-10 | CARBOPLATIN + ETOPOSIDE | N | N | 310017693 | CARBOPLATIN + ETOPOSIDE |
| 310003321 | 310001401 | null | 77.4 | null | 2013-03-27 | 2013-03-28 | CHOP R - 21 days | 2 | Y | 310017693 | CHOP R |
| 310003322 | 310001401 | 1.77 | 5.3 | Palliative (P) | 2015-11-06 | 2015-11-07 | Carboplatin + Etoposide iv&po | 02 | null | 310017693 | CARBOPLATIN + ETOPOSIDE |
| 310003323 | 310010321 | 1.62 | 9.8 | null | 2017-12-03 | 2017-12-08 | Ipilimumab | 02 | N | 310017700 | IPILIMUMAB |
| 310003324 | 310001402 | 1.79 | 77.9 | Palliative (P) | 2014-10-28 | 2014-10-29 | PEMBROLIZUMAB | N | N | 310017702 | PEMBROLIZUMAB |
| 310003325 | 310001402 | 1.79 | null | Neo-adjuvant (N) | 2013-04-16 | 2013-04-25 | Doxorubicin 75mg/m2 | N | null | 310017702 | DOXORUBICIN |
| 310003326 | 310001402 | null | 78.6 | Curative (C) | 2015-12-24 | 2015-12-24 | Trial Unspecified | 01 | N | 310017702 | TRIAL |
| 310003327 | 310001402 | null | null | Curative (C) | 2014-10-25 | 2014-11-19 | CHOP R - 21 days | N | N | 310017702 | CHOP R |
| 310003328 | 310001402 | null | 66.5 | Curative (C) | 2017-10-11 | 2017-10-12 | Retinoblastoma JOE | N | N | 310017702 | CEV |
| 310003329 | 310001403 | 1.06 | 57.3 | Curative (C) | 2017-06-01 | 2017-06-16 | Retinoblastoma JOE | N | N | 310017713 | CEV |